Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Jianzhijia Pharmaceutical Chain Group Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 3/6
Jianzhijia Pharmaceutical Chain Group has a total shareholder equity of CN¥2.7B and total debt of CN¥2.7B, which brings its debt-to-equity ratio to 98.8%. Its total assets and total liabilities are CN¥10.4B and CN¥7.6B respectively. Jianzhijia Pharmaceutical Chain Group's EBIT is CN¥523.5M making its interest coverage ratio 4.4. It has cash and short-term investments of CN¥796.2M.
Anahtar bilgiler
98.8%
Borç/özkaynak oranı
CN¥2.69b
Borç
| Faiz karşılama oranı | 4.4x |
| Nakit | CN¥796.22m |
| Eşitlik | CN¥2.72b |
| Toplam yükümlülükler | CN¥7.64b |
| Toplam varlıklar | CN¥10.37b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
What Is Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Share Price Doing?
Jul 16
Investors Don't See Light At End Of Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Tunnel And Push Stock Down 28%
Jun 19Improved Earnings Required Before Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) Shares Find Their Feet
Feb 27Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 605266's short term assets (CN¥4.3B) do not cover its short term liabilities (CN¥5.2B).
Uzun Vadeli Yükümlülükler: 605266's short term assets (CN¥4.3B) exceed its long term liabilities (CN¥2.5B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 605266's net debt to equity ratio (69.6%) is considered high.
Borcun Azaltılması: 605266's debt to equity ratio has increased from 15.5% to 98.8% over the past 5 years.
Borç Kapsamı: 605266's debt is well covered by operating cash flow (28.4%).
Faiz Kapsamı: 605266's interest payments on its debt are well covered by EBIT (4.4x coverage).